Gene testing and reporting for Ovarian cancer specimens
- Buyer
- NHS Greater Glasgow and Clyde
- Published
- 2026-11-19
- Deadline
- Not provided
- Sources
- UK_FTS
- Value
- Not provided
Description
The description is in the source language.
NHS Greater Glasgow and Clyde, Laboratory Genetics requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.
CPV: 85145000
Membership
Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.
Read